Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Fearon

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanismsD T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3D P Vik, D T Fearon
The Journal of Biological Chemistry|November 5, 1985
The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand bindingJ J Weis, D T Fearon
Annals of the New York Academy of Sciences|June 13, 1975
Inhibition of complement-derived enzymesD T Fearon, K F Austen
Annual Review of Immunology|January 1, 1995
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunityD T Fearon, R H Carter
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Altered surface distribution of both C3b receptors and Fc receptors on neutrophils induced by anti-C3b receptor or aggregated IgGR M Jack, D T Fearon
La Nouvelle Presse Medicale|June 9, 1979
[Alternative complement pathway (author's transl)]M Kazatchkine, U Nydegger, D T Fearon
Current Opinion in Immunology|June 1, 1997
Co-receptors of B lymphocytesL O'Rourke, R Tooze, D T Fearon
Clinical and Experimental Immunology|April 1, 1984
Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysisJ Lee, R M Hakim, D T Fearon
Science (New York, N.Y.)|October 4, 1991
Suppression of the immune response by a soluble complement receptor of B lymphocytesT Hebell, J M Ahearn, D T Fearon
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanismsD T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3D P Vik, D T Fearon
The Journal of Biological Chemistry|November 5, 1985
The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand bindingJ J Weis, D T Fearon
Annals of the New York Academy of Sciences|June 13, 1975
Inhibition of complement-derived enzymesD T Fearon, K F Austen
Annual Review of Immunology|January 1, 1995
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunityD T Fearon, R H Carter
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Altered surface distribution of both C3b receptors and Fc receptors on neutrophils induced by anti-C3b receptor or aggregated IgGR M Jack, D T Fearon
La Nouvelle Presse Medicale|June 9, 1979
[Alternative complement pathway (author's transl)]M Kazatchkine, U Nydegger, D T Fearon
Current Opinion in Immunology|June 1, 1997
Co-receptors of B lymphocytesL O'Rourke, R Tooze, D T Fearon
Clinical and Experimental Immunology|April 1, 1984
Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysisJ Lee, R M Hakim, D T Fearon
Science (New York, N.Y.)|October 4, 1991
Suppression of the immune response by a soluble complement receptor of B lymphocytesT Hebell, J M Ahearn, D T Fearon
Pageof 18